Voglio sapere a riguardo di…

Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel SEP
CE21004: Research Grants for Preventing Violence and Violence Related Injury.
Date: May 2526, 2021.
Time: 8:30 a.m.5:00 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F63, Atlanta, Georgia 30341, Telephone 404
6390913, MWalters@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

Operating Officer, CDC, pursuant to Public Law 92463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel SEP
CE21005, The CDC National Centers of Excellence in Youth Violence Prevention YVPCs: Rigorous Evaluation of Prevention Strategies to Prevent and Reduce Community Rates of Youth Violence.
Date: June 2224, 2021.
Time: 8:30 a.m.5:00 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F63, Atlanta, Georgia 30341, Telephone 404
6390913, MWalters@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

FR Doc. 202102051 Filed 12921; 8:45 am
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

BILLING CODE 416318P

FR Doc. 202102054 Filed 12921; 8:45 am BILLING CODE 416318P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief
VerDate Sep<11>2014

16:57 Jan 29, 2021

Jkt 253001

Statement of Organization, Functions, and Delegations of Authority Part C Centers for Disease Control and Prevention of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services 45 FR 6777276, dated October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended most recently at 86 FR 63366340, dated
PO 00000

Frm 00038

Fmt 4703

Sfmt 4703

7725

January 20, 2021 is amended to reflect the Order of Succession for the Centers for Disease Control and Prevention.
Section CC, Order of Succession, is hereby amended as follows:
Delete in its entirety Section CC, Order of Succession, and insert the following:
During the absence or disability of the Director, Centers for Disease Control and Prevention CDC, or in the event of a vacancy in that office, the first official listed below who is available shall act as Director, except that during a planned period of absence, the Director may specify a different order of succession:
1. Principal Deputy Director 2. Chief Medical Officer 3. Deputy Director for Public Health Service and Implementation Science 4. Deputy Director for Infectious Diseases 5. Deputy Director for Public Health Science and Surveillance 6. Deputy Director for Non-Infectious Diseases 7. Director, National Institute for Occupational Safety and Health Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202102093 Filed 12921; 8:45 am BILLING CODE 416018P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
E:FRFM01FEN1.SGM

01FEN1